February 7, 2018 / 12:48 PM / 9 months ago

BRIEF-Case Western Reserve, Sangamo Therapeutics get $11 Mln NIH Grant

Feb 7 (Reuters) - Sangamo Therapeutics Inc:

* CASE WESTERN RESERVE AND SANGAMO THERAPEUTICS ANNOUNCE $11 MILLION NIH GRANT FOR STUDY OF GENE-EDITED T CELLS FOR VIRAL ERADICATION OF HIV

* NO SB-728-T PRODUCT-RELATED SERIOUS ADVERSE EVENTS WERE REPORTED IN SANGAMO’S SB-728-T CLINICAL TRIALS

* CO WILL BE CONTRIBUTING MATERIALS, EQUIPMENT, AND MANUFACTURING EXPERTISE FOR STUDY, WHICH IS EXPECTED TO BEGIN IN 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below